Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 110892325 | 11089232 | 5 | F | 2009 | 20160921 | 20150505 | 20160926 | EXP | US-PFIZER INC-2015141563 | PFIZER | 62.00 | YR | F | Y | 0.00000 | 20160926 | CN | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 110892325 | 11089232 | 1 | PS | LYRICA | PREGABALIN | 1 | Oral | 150 MG, 1X/DAY | U | 21446 | 150 | MG | CAPSULE, HARD | QD | |||||
| 110892325 | 11089232 | 2 | SS | LYRICA | PREGABALIN | 1 | Oral | 100 MG, 2X/DAY | U | 21446 | 100 | MG | CAPSULE, HARD | BID | |||||
| 110892325 | 11089232 | 3 | SS | LYRICA | PREGABALIN | 1 | Oral | 75 MG CAPS, 2 CAPS AT BEDTIME | U | 21446 | 150 | MG | CAPSULE, HARD | ||||||
| 110892325 | 11089232 | 4 | SS | LYRICA | PREGABALIN | 1 | Oral | 150 MG AT NIGHT AND 35 MG IN THE MORNING | U | 21446 | 185 | MG | CAPSULE, HARD | ||||||
| 110892325 | 11089232 | 5 | SS | LYRICA | PREGABALIN | 1 | Oral | 150 MG, 3X/DAY (EVERY 8 HOURS) | U | 21446 | 150 | MG | CAPSULE, HARD | TID | |||||
| 110892325 | 11089232 | 6 | SS | LYRICA | PREGABALIN | 1 | Oral | 50 MG, 2X/DAY (EVERY 12 HOURS) | U | 21446 | 50 | MG | CAPSULE, HARD | BID | |||||
| 110892325 | 11089232 | 7 | C | WELLBUTRIN SR | BUPROPION HYDROCHLORIDE | 1 | 100 MG, DAILY | 0 | 100 | MG | TABLET | ||||||||
| 110892325 | 11089232 | 8 | C | NAPROXEN. | NAPROXEN | 1 | 500 MG, 2X/DAY | 0 | 500 | MG | TABLET | BID | |||||||
| 110892325 | 11089232 | 9 | C | ZANAFLEX | TIZANIDINE HYDROCHLORIDE | 1 | 4 MG TABS AT 0.5 TO 1 TAB EVERY 8 HOURS AS NEEDED (UP TO THREE A DAY) | 0 | TABLET | TID | |||||||||
| 110892325 | 11089232 | 10 | C | SAVELLA | MILNACIPRAN HYDROCHLORIDE | 1 | 12.5 MG, DAILY | 0 | 12.5 | MG | |||||||||
| 110892325 | 11089232 | 11 | C | SAVELLA | MILNACIPRAN HYDROCHLORIDE | 1 | 25 UNK, UNK | 0 | |||||||||||
| 110892325 | 11089232 | 12 | C | SAVELLA | MILNACIPRAN HYDROCHLORIDE | 1 | 50 MG, UNK | 0 | 50 | MG | |||||||||
| 110892325 | 11089232 | 13 | C | NORCO | ACETAMINOPHENHYDROCODONE BITARTRATE | 1 | 5/325 MG, 3 TO 4 A DAY | 0 | |||||||||||
| 110892325 | 11089232 | 14 | C | MS CONTIN | MORPHINE SULFATE | 1 | 15 MG, EVERY 12 HOURS | 0 | 15 | MG | TABLET | BID | |||||||
| 110892325 | 11089232 | 15 | C | HYDROCODONE, ACETOMINOPHEN | 2 | 5-325 MG TABS 0.5 TO 1 TAB EVERY 8 HOURS | 0 | TABLET | TID | ||||||||||
| 110892325 | 11089232 | 16 | C | AROMASIN | EXEMESTANE | 1 | 25 MG, 1X/DAY | 0 | 25 | MG | TABLET | QD | |||||||
| 110892325 | 11089232 | 17 | C | BONIVA | IBANDRONATE SODIUM | 1 | 150 MG, MONTHLY | 0 | 150 | MG | TABLET | /month | |||||||
| 110892325 | 11089232 | 18 | C | K-LOR | POTASSIUM CHLORIDE | 1 | 1 PILL, 2X/DAY | 0 | 1 | DF | BID | ||||||||
| 110892325 | 11089232 | 19 | C | PREDNISONE. | PREDNISONE | 1 | 1 MG, 2X/DAY | 0 | 1 | MG | TABLET | BID | |||||||
| 110892325 | 11089232 | 20 | C | FOLIC ACID. | FOLIC ACID | 1 | 1 MG, 1X/DAY | 0 | 1 | MG | TABLET | QD | |||||||
| 110892325 | 11089232 | 21 | C | LEVOTHYROXINE SODIUM. | LEVOTHYROXINE SODIUM | 1 | 1 DF, DAILY | 0 | 1 | DF | |||||||||
| 110892325 | 11089232 | 22 | C | MEGACE ES | MEGESTROL ACETATE | 1 | UNK, AS NEEDED | 0 | |||||||||||
| 110892325 | 11089232 | 23 | C | CYCLOPHOSPHAMIDE. | CYCLOPHOSPHAMIDE | 1 | UNK, MONTHLY | 0 | /month | ||||||||||
| 110892325 | 11089232 | 24 | C | DOCETAXEL. | DOCETAXEL | 1 | UNK, MONTHLY | 0 | /month | ||||||||||
| 110892325 | 11089232 | 25 | C | EMEND | APREPITANT | 1 | 80 MG, MONTHLY | 0 | 80 | MG | /month | ||||||||
| 110892325 | 11089232 | 26 | C | CEPHALEXIN. | CEPHALEXIN | 1 | 500 MG, 4X/DAY | 0 | 500 | MG | QID | ||||||||
| 110892325 | 11089232 | 27 | C | CALCIUM | CALCIUM | 1 | 1 PILL, 2X/DAY | 0 | 1 | DF | BID | ||||||||
| 110892325 | 11089232 | 28 | C | TOPAMAX | TOPIRAMATE | 1 | 50 MG, 1X/DAY AT NIGHT | 0 | 50 | MG | QD | ||||||||
| 110892325 | 11089232 | 29 | C | BACLOFEN. | BACLOFEN | 1 | 10 MG, 3X/DAY | 0 | 10 | MG | TID | ||||||||
| 110892325 | 11089232 | 30 | C | AMITRIPTYLINE | AMITRIPTYLINE | 1 | 25 MG, AS NEEDED EVERY NIGHT | 0 | 25 | MG | |||||||||
| 110892325 | 11089232 | 31 | C | HYDROCODONE | HYDROCODONE | 1 | BETWEEN 0 TO 2 A DAY | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 110892325 | 11089232 | 1 | Neck pain |
| 110892325 | 11089232 | 2 | Post laminectomy syndrome |
| 110892325 | 11089232 | 3 | Pain |
| 110892325 | 11089232 | 4 | Polymyalgia rheumatica |
| 110892325 | 11089232 | 5 | Pain |
| 110892325 | 11089232 | 14 | Pain |
| 110892325 | 11089232 | 15 | Pain |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 110892325 | 11089232 | OT |
| 110892325 | 11089232 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 110892325 | 11089232 | Arthralgia | |
| 110892325 | 11089232 | Back pain | |
| 110892325 | 11089232 | Body mass index increased | |
| 110892325 | 11089232 | Bone pain | |
| 110892325 | 11089232 | Breast cancer female | |
| 110892325 | 11089232 | Cervical spinal stenosis | |
| 110892325 | 11089232 | Condition aggravated | |
| 110892325 | 11089232 | Cough | |
| 110892325 | 11089232 | Drug ineffective for unapproved indication | |
| 110892325 | 11089232 | Hypoaesthesia | |
| 110892325 | 11089232 | Insomnia | |
| 110892325 | 11089232 | Intervertebral disc degeneration | |
| 110892325 | 11089232 | Joint range of motion decreased | |
| 110892325 | 11089232 | Memory impairment | |
| 110892325 | 11089232 | Musculoskeletal stiffness | |
| 110892325 | 11089232 | Myofascial pain syndrome | |
| 110892325 | 11089232 | Pain in extremity | |
| 110892325 | 11089232 | Sedation | |
| 110892325 | 11089232 | Sensory loss | |
| 110892325 | 11089232 | Swelling | |
| 110892325 | 11089232 | Tenderness | |
| 110892325 | 11089232 | Vertebral osteophyte |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 110892325 | 11089232 | 22 | 2013 | 0 | ||
| 110892325 | 11089232 | 23 | 2013 | 0 | ||
| 110892325 | 11089232 | 24 | 2013 | 0 | ||
| 110892325 | 11089232 | 25 | 2013 | 0 | ||
| 110892325 | 11089232 | 26 | 2013 | 0 | ||
| 110892325 | 11089232 | 28 | 20140401 | 0 |